Our data-driven analysis reveals how major pharma companies stack up across key AI readiness metrics, from technical partnerships to organizational culture.
With valuations, funding rounds, and revenue moving at breakneck speeds, sizing up the market for enterprise AI agents & copilots can be challenging. Mining CB insights data reveals a market worth billions — and one poised for exponential growth.
CB Insights' emerging technology insights platform provides all the analysis and data from this newsletter. Our data is the easiest way to discover and respond to emerging tech.